|
|||||
|
|
Adalimumab for the treatment of moderate to severe psoriasis: subanalysis of effects on scalp and nails in the BELIEVE study |
|
| Authors: | D. Thaçi K. Unnebrink M. Sundaram S. Sood Y. Yamaguchi |
| Affiliation: | 1. Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany;2. AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany;3. AbbVie Inc., North Chicago, IL, USA |
| Abstract: | |
| Keywords: | |